Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Chinese Patent Office
Deloitte
Covington
Baxter

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,861,607

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,861,607 protect, and when does it expire?

Patent 9,861,607 protects SILENOR and is included in one NDA.

This patent has eleven patent family members in four countries.

Summary for Patent: 9,861,607
Title:Methods of using low-dose doxepin for the improvement of sleep
Abstract: Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
Inventor(s): Rogowski; Roberta L. (Rancho Santa Fe, CA), Dube; Susan E. (Carlsbad, CA), Jochelson; Philip (San Diego, CA), Kavey; Neil B. (Chappaqua, NY)
Assignee: Procom One, Inc. (San Marcos, TX) Pernix Sleep, Inc. (Morristown, NJ)
Application Number:15/344,710
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 9,861,607

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Currax SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 RX Yes No   Try a Free Trial   Try a Free Trial TREATMENT OF INSOMNIA   Try a Free Trial
Currax SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF INSOMNIA   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,861,607

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2687118   Try a Free Trial
Canada 2687124   Try a Free Trial
European Patent Office 2026792   Try a Free Trial
Japan 2009537553   Try a Free Trial
Japan 2009537554   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Covington
AstraZeneca
Cantor Fitzgerald
Julphar
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.